Efficacy and Safety of Telbivudine in Chinese Children and Adolescents with Chronic Hepatitis B

被引：0
|
作者：
Zhang, Hongfei [1 ]
Zhu, Shishu [1 ]
Dong, Yi [1 ]
Wang, Limin [1 ]
Xu, Zhiqiang [1 ]
Chen, Dawei [1 ]
Gan, Yu [1 ]
Wang, Fuchuan [1 ]
机构：
[1] 302 Hosp PLA, Beijing, Peoples R China
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：1123A / 1124A
页数：2
相关论文
共 50 条
  • [31] Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
    Zhao, Shushan
    Tang, Lanhua
    Fan, Xuegong
    Chen, Lizhang
    Zhou, Rongrong
    Dai, Xiahong
    VIROLOGY JOURNAL, 2010, 7
  • [32] Safety, efficacy and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to < 18) with chronic hepatitis B
    Sokal, E.
    Jonas, M.
    Kelly, D.
    Pollack, H.
    Mizerski, J.
    Sorbel, J.
    Frederick, D.
    Rousseau, F.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 : 28 - 28
  • [33] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
    Schwarz, Kathleen B.
    Bezerra, Jorge
    Choe, Byung-ho
    Lin, Chuan-Hao
    Abramov, Frida
    Wang, Hongyuan
    Liu, Yang
    Flaherty, John F.
    Pacurar, Daniela
    Kim, Kyung Mo
    Khaertynova, Ilsiyar
    Shalimar
    Wu, Jia-Feng
    Tandon, Manish
    Rosenthal, Philip
    Morozov, Viacheslav
    Sokal, Etinne
    Chang, Mei-Hwei
    GASTROENTEROLOGY, 2023, 164 (06) : S1237 - S1238
  • [34] Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
    Shushan Zhao
    Lanhua Tang
    Xuegong Fan
    Lizhang Chen
    Rongrong Zhou
    Xiahong Dai
    Virology Journal, 7
  • [35] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
    Schwarz, Kathleen B.
    Bezerra, Jorge A.
    Choe, Byung-Ho
    Lin, Chuan-Hao
    Abramov, Frida
    Nguyen, Anh-Hoa
    Liu, Yang
    Flaherty, John F.
    Pacurar, Daniela
    Kim, Kyung Mo
    Khaertynova, Ilsiyar
    Shalimar
    Wu, Jia-Feng
    Tandon, Manish
    Rosenthal, Philip
    Morozov, Viacheslav
    Sokal, Etienne
    Chang, Mei-Hwei
    HEPATOLOGY, 2022, 76 : S300 - S301
  • [36] Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine
    Safadi, Rifaat
    Xie, Qing
    Chen, Yagang
    Yin, You-Kuan
    Wei, Lai
    Hwang, Seong Gyu
    Zuckerman, Eli
    Jia, Ji-Dong
    Lopez, Patricia
    LIVER INTERNATIONAL, 2011, 31 (05) : 667 - 675
  • [37] Telbivudine myopathy in a patient with chronic hepatitis B
    Min Wang
    Yuwei Da
    Haodong Cai
    Yan Lu
    Liyong Wu
    Jianping Jia
    International Journal of Clinical Pharmacy, 2012, 34 : 422 - 425
  • [38] Therapy of chronic hepatitis B: focus on telbivudine
    Gaeta, Giovanni Battista
    Stornaiuolo, Gianfranca
    DIGESTIVE AND LIVER DISEASE, 2007, 39 : S372 - S378
  • [39] Treatment of chronic hepatitis B: focus on telbivudine
    Lui, Yanni Y. N.
    Chan, Henry L. Y.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (03) : 259 - 268
  • [40] Telbivudine myopathy in a patient with chronic hepatitis B
    Wang, Min
    Da, Yuwei
    Cai, Haodong
    Lu, Yan
    Wu, Liyong
    Jia, Jianping
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (03) : 422 - 425
12345